Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion type Assertion NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_head.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion description "[Targeting PLK1 in OS with NMS-P937 in association with conventional chemotherapeutic drugs may be a new interesting therapeutic option, since this approach has proved to be active against drug resistant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion evidence source_evidence_literature NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion SIO_000772 25193492 NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion wasDerivedFrom befree-2016 NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.
- NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_assertion wasGeneratedBy ECO_0000203 NP1217405.RAOya-E0iaIY_LW8r2MPTf6u5JMgpg-RGduEcFk9lMxAs130_provenance.